346 related articles for article (PubMed ID: 26600070)
41. A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase.
Mao Y; Huang Y; Buczek-Thomas JA; Ethen CM; Nugent MA; Wu ZL; Zaia J
J Biol Chem; 2014 Dec; 289(49):34141-51. PubMed ID: 25336655
[TBL] [Abstract][Full Text] [Related]
42. New Advances of Heparanase and Heparanase-2 in Human Diseases.
Jin H; Cui M
Arch Med Res; 2018 Oct; 49(7):423-429. PubMed ID: 30850186
[TBL] [Abstract][Full Text] [Related]
43. Characterization of heparanase from a rat parathyroid cell line.
Podyma-Inoue KA; Yokote H; Sakaguchi K; Ikuta M; Yanagishita M
J Biol Chem; 2002 Sep; 277(36):32459-65. PubMed ID: 12077130
[TBL] [Abstract][Full Text] [Related]
44. Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin.
Elli S; Guerrini M
Adv Exp Med Biol; 2020; 1221():169-188. PubMed ID: 32274710
[TBL] [Abstract][Full Text] [Related]
45. Modulating Heparanase Activity: Tuning Sulfation Pattern and Glycosidic Linkage of Oligosaccharides.
Zhu S; Li J; Loka RS; Song Z; Vlodavsky I; Zhang K; Nguyen HM
J Med Chem; 2020 Apr; 63(8):4227-4255. PubMed ID: 32216347
[TBL] [Abstract][Full Text] [Related]
46. Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.
O'Callaghan P; Zhang X; Li JP
J Histochem Cytochem; 2018 Apr; 66(4):305-319. PubMed ID: 29290138
[TBL] [Abstract][Full Text] [Related]
47. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
48. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses.
Ferro V
Expert Opin Ther Targets; 2013 Aug; 17(8):965-75. PubMed ID: 23789629
[TBL] [Abstract][Full Text] [Related]
49. The anti-inflammatory effect of the synthetic antimicrobial peptide 19-2.5 in a murine sepsis model: a prospective randomized study.
Schuerholz T; Doemming S; Hornef M; Martin L; Simon TP; Heinbockel L; Brandenburg K; Marx G
Crit Care; 2013 Jan; 17(1):R3. PubMed ID: 23302299
[TBL] [Abstract][Full Text] [Related]
50. Radiolabeled heparan sulfate immobilized on microplate as substrate for the detection of heparanase activity.
Nardella C; Steinkühler C
Anal Biochem; 2004 Sep; 332(2):368-75. PubMed ID: 15325306
[TBL] [Abstract][Full Text] [Related]
51. Ulinastatin attenuates pulmonary endothelial glycocalyx damage and inhibits endothelial heparanase activity in LPS-induced ARDS.
Wang L; Huang X; Kong G; Xu H; Li J; Hao D; Wang T; Han S; Han C; Sun Y; Liu X; Wang X
Biochem Biophys Res Commun; 2016 Sep; 478(2):669-75. PubMed ID: 27498004
[TBL] [Abstract][Full Text] [Related]
52. Role of heparan sulfate in dextral heart looping in chick.
Yue X; Schultheiss TM; McKenzie EA; Rosenberg RD
Glycobiology; 2004 Aug; 14(8):745-55. PubMed ID: 15070861
[TBL] [Abstract][Full Text] [Related]
53. Chemical toolbox to interrogate Heparanase-1 activity.
Rabinowitz ZM; Somers J; Wang Z; Cui L
Curr Opin Chem Biol; 2024 Jun; 80():102452. PubMed ID: 38555836
[TBL] [Abstract][Full Text] [Related]
54. Heparanase activity in cultured endothelial cells.
Godder K; Vlodavsky I; Eldor A; Weksler BB; Haimovitz-Freidman A; Fuks Z
J Cell Physiol; 1991 Aug; 148(2):274-80. PubMed ID: 1880155
[TBL] [Abstract][Full Text] [Related]
55. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
Savion N; Disatnik MH; Nevo Z
J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
[TBL] [Abstract][Full Text] [Related]
56. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
[TBL] [Abstract][Full Text] [Related]
57. Deciphering mode of action of heparanase using structurally defined oligosaccharides.
Peterson S; Liu J
J Biol Chem; 2012 Oct; 287(41):34836-43. PubMed ID: 22893710
[TBL] [Abstract][Full Text] [Related]
58. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
[TBL] [Abstract][Full Text] [Related]
59. Histidine-rich glycoprotein binds heparanase and regulates its enzymatic activity and cell surface interactions.
Poon IK; Yee DY; Jones AL; Wood RJ; Davis DS; Freeman C; Parish CR; Hulett MD
Int J Biochem Cell Biol; 2010 Sep; 42(9):1507-16. PubMed ID: 20561914
[TBL] [Abstract][Full Text] [Related]
60. Structural Insights into Pixatimod (PG545) Inhibition of Heparanase, a Key Enzyme in Cancer and Viral Infections.
Chhabra M; Wilson JC; Wu L; Davies GJ; Gandhi NS; Ferro V
Chemistry; 2022 Feb; 28(11):e202104222. PubMed ID: 34981584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
